Stratification of clear cell renal cell carcinoma by signaling pathway analysis

被引:7
|
作者
Cremona, Mattia [1 ]
Espina, Virginia [2 ]
Caccia, Dario [1 ]
Veneroni, Silvia [1 ]
Colecchia, Maurizio [3 ]
Pierobon, Mariaelena [2 ]
Deng, Jianghong [2 ]
Mueller, Claudius [2 ]
Procopio, Giuseppe [4 ]
Lanzi, Cinzia [1 ]
Daidone, Maria Grazia [1 ]
Cho, William C. S. [5 ]
Petricoin, Emanuel F. [2 ]
Liotta, Lance [2 ]
Bongarzone, Italia [1 ]
机构
[1] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy
[2] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA USA
[3] Fdn IRCCS Ist Nazl Tumori, Dept Pathol, Milan, Italy
[4] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy
[5] Queen Elizabeth Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China
关键词
autophagy; HIF; hypoxia; mTOR; renal cell carcinoma; reverse-phase protein array; signaling pathway; GROWTH-FACTOR RECEPTOR; TARGETED THERAPY; CANCER; AUTOPHAGY; MTOR; EGFR; VHL; PHOSPHORYLATION; MICRODISSECTION; INACTIVATION;
D O I
10.1586/14789450.2014.893193
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Investigation of cell signaling pathways in 16 clear cell renal cell carcinomas to identify groups based on commonly shared phosphorylation-driven signaling networks. Using laser capture microdissection and reverse-phase protein arrays, we profiled 75 key nodes spanning signaling pathways important in tumorigenesis. Analysis revealed significantly different (P < 0.05) signaling levels for 27 nodes between two groups of samples, designated A (4 samples; high EGFR, RET, and RASGFR1 levels, converging to activate AKT/mTOR) and B (12 samples; high ERK1/2 and STAT phosphorylation). Group B was further partitioned into groups C (7 samples; elevated expression of LC3B) and D (5 samples; activation of Src and STAT). Network analysis indicated that group A was characterized by signaling pathways related to cell cycle and proliferation, and group B by pathways related to cell death and survival. Homogeneous clear cell renal cell carcinomas could be stratified into at least two major functional groups.
引用
收藏
页码:237 / 249
页数:13
相关论文
共 50 条
  • [31] An analysis of phosphatidic acid for clear cell renal cell carcinoma
    Utsunomiya, Noriaki
    Yamasaki, Toshinari
    Takeda, Masashi
    Sumiyoshi, Takayuki
    Goto, Takayuki
    Akamatsu, Shusuke
    Kobayashi, Takashi
    Inoue, Takahiro
    Kamba, Tomomi
    Ogawa, Osamu
    CANCER SCIENCE, 2018, 109 : 328 - 328
  • [32] Expression of the Sonic Hedgehog pathway components in clear cell renal cell carcinoma
    Kotulak-Chrzaszcz, Anna
    Klacz, Jakub
    Matuszewski, Marcin
    Kmiec, Zbigniew
    Wierzbicki, Piotr M.
    ONCOLOGY LETTERS, 2019, 18 (06) : 5801 - 5810
  • [33] Cabozantinib for the treatment of patients with metastatic non-clear cell renal cell carcinoma: A retrospective analysis
    Campbell, Matthew T.
    Bilen, Mehmet A.
    Shah, Amishi Y.
    Lemke, Emily
    Jonasch, E.
    Venkatesan, A. M.
    Altinmakas, E.
    Duran, C.
    Msaouel, Pavlos
    Tannir, N. M.
    EUROPEAN JOURNAL OF CANCER, 2018, 104 : 188 - 194
  • [34] Wnt signaling pathway analysis in renal cell carcinoma in young patients
    Bruder, Elisabeth
    Moch, Holger
    Ehrlich, David
    Leuschner, Ivo
    Harms, Dieter
    Argani, Pedram
    Briner, Jakob
    Graf, Norbert
    Selle, Barbara
    Rufle, Alex
    Paulussen, Michael
    Koesters, Robert
    MODERN PATHOLOGY, 2007, 20 (12) : 1217 - 1229
  • [35] Gene expression profiling of clear cell papillary renal cell carcinoma: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma
    Fisher, Kevin E.
    Yin-Goen, Qiqin
    Alexis, Dianne
    Sirintrapun, Joseph S.
    Harrison, William
    Isett, R. Benjamin
    Rossi, Michael R.
    Moreno, Carlos S.
    Young, Andrew N.
    Osunkoya, Adeboye O.
    MODERN PATHOLOGY, 2014, 27 (02) : 222 - 230
  • [36] Analysis of HIF-1α expression and genetic polymorphisms in human clear cell renal cell carcinoma
    Vargova, Daniela
    Kolkova, Zuzana
    Dargaj, Jan
    Bris, Lukas
    Luptak, Jan
    Dankova, Zuzana
    Franova, Sona
    Svihra, Jan
    Slavik, Pavol
    Sutovska, Martina
    PATHOLOGY & ONCOLOGY RESEARCH, 2024, 29
  • [37] Difference between RAT and clear cell papillary renal cell carcinoma/clear renal cell carcinoma
    Michal Michal
    Ondrej Hes
    Naoto Kuroda
    Dmitry V. Kazakov
    Milan Hora
    Virchows Archiv, 2009, 454 : 719 - 719
  • [38] Microarray analysis of microRNA expression in renal clear cell carcinoma
    Huang, Y.
    Dai, Y.
    Yang, J.
    Chen, T.
    Yin, Y.
    Tang, M.
    Hu, C.
    Zhang, L.
    EJSO, 2009, 35 (10): : 1119 - 1123
  • [39] The significance of TIMD4 expression in clear cell renal cell carcinoma
    Yano, Hiromu
    Motoshima, Takanobu
    Ma, Chaoya
    Pan, Cheng
    Yamada, Sohsuke
    Nakayama, Toshiyuki
    Kitada, Shohei
    Fujimoto, Naohiro
    Kamba, Tomomi
    Takeya, Motohiro
    Komohara, Yoshihiro
    MEDICAL MOLECULAR MORPHOLOGY, 2017, 50 (04) : 220 - 226
  • [40] Metastatic risk stratification of clear cell renal cell carcinoma patients based on genomic aberrations
    Grimm, Julia
    Zeuschner, Philip
    Janssen, Martin
    Wagenpfeil, Stefan
    Hartmann, Arndt
    Stoehr, Christine
    Keck, Bastian
    Kahlmeyer, Andreas
    Stoeckle, Michael
    Junker, Kerstin
    GENES CHROMOSOMES & CANCER, 2019, 58 (09) : 612 - 618